Had My Patient Come In Today, We May Have Had Other Options Had My Patient Come In Today, We May Have Had Other Options

Only around 3% of nonsquamous NSCLC tumors carry HER2 mutations, and they are associated with female sex, never-smokers, and a poor prognosis. Now these patients can be offered a targeted therapy.MDedge
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology Commentary Source Type: news